Emmessar Biotech Nutrition Ltd vs Privi Speciality Chemicals Ltd Stock Comparison

Home

Insights

Stock Comparison

Last Updated on: Mar 22, 2026

Key Highlights

The Latest Trading Price of Emmessar Biotech & Nutrition Ltd is ₹ 24.34 as of 20 Mar 15:30 . The P/E Ratio of Emmessar Biotech & Nutrition Ltd changed from 0 on March 2021 to 0 on March 2025 . This represents a CAGR of 0.0% over 5 yearsThe P/E Ratio of Privi Speciality Chemicals Ltd changed from 28.3 on March 2021 to 35.7 on March 2025 . This represents a CAGR of 4.76% over 5 years The Market Cap of Emmessar Biotech & Nutrition Ltd changed from ₹ 0 crore on March 2021 to ₹ 0 crore on March 2025 . This represents a CAGR of 0.0% over 5 yearsThe Market Cap of Privi Speciality Chemicals Ltd changed from ₹ 3312 crore on March 2021 to ₹ 6669 crore on March 2025 . This represents a CAGR of 15.02% over 5 years The revenue of Emmessar Biotech & Nutrition Ltd for the Dec '25 is ₹ 0 crore as compare to the Sep '25 revenue of ₹ 0 crore. This represent the decline of 0% The revenue of Privi Speciality Chemicals Ltd for the Dec '25 is ₹ 611.15 crore as compare to the Sep '25 revenue of ₹ 678.82 crore. This represent the decline of -9.97% The ebitda of Emmessar Biotech & Nutrition Ltd for the Dec '25 is ₹ 0 crore as compare to the Sep '25 ebitda of ₹ 0 crore. This represent the decline of 0% The ebitda of Privi Speciality Chemicals Ltd for the Dec '25 is ₹ 157.85 crore as compare to the Sep '25 ebitda of ₹ 182.14 crore. This represent the decline of -13.34% The net profit of Emmessar Biotech & Nutrition Ltd changed from ₹ 0 crore to ₹ 0 crore over 7 quarters. This represents a CAGR of 0.0% The net profit of Privi Speciality Chemicals Ltd changed from ₹ 31.45 crore to ₹ 74.85 crore over 7 quarters. This represents a CAGR of 64.13% The Dividend Payout of Emmessar Biotech & Nutrition Ltd changed from 0 % on March 2021 to 0 % on March 2025 . This represents a CAGR of 0.0% over 5 yearsThe Dividend Payout of Privi Speciality Chemicals Ltd changed from 6.68 % on March 2021 to 10.32 % on March 2025 . This represents a CAGR of 9.09% over 5 years .

About Emmessar Biotech & Nutrition Ltd

Emmessar Biotech & Nutrition Limited (EBNL), originally established on 17th March 1992 as Emmessar Chemical Industries Ltd (ECIL) started its operations in manufacturing Super Specialty Fine Chemicals.
The Company has so far, succeeded in developing many Specialty Fine Chemicals.
ECIL gained official recognition for its R&D from DSIR, Ministry of Science & Technology, Government of India, New-Delhi in early 1996.
To better represent its new core activity, a change in the Company name from Emmessar Chemical Industries Ltd (ECIL) to Emmessar Biotech & Nutrition Ltd (EBNL) on April 7, 2000, was made essential. On realizing that some of the specialty chemicals developed & exported to USA & Europe was being used in producing healthcare formulations, the Company plunged into a new venture in the Healthcare business, where phenomenal growth in the coming decades was anticipated.

About Privi Speciality Chemicals Ltd

Privi Speciality Chemicals Limited is India's leading manufacturer, supplier, and exporter of aroma and fragrance chemicals and a globally trusted partner and supplier of bulk aroma chemicals.
The Company has in-house integrated manufacturing facilities situated at Mahad in Maharashtra and Jhagadia in Gujarat with knowledge, expertise and capacity to perform critical reactions like Hydrogenation, Condensation, Grignard reactions, as well as unit operations like Pyrolysis, Reactive Distillation, High Vacuum Distillation, Continuous Distillation to deliver consistency. Privi Speciality Chemicals Limited was initially incorporated as 'Fairchem Speciality Limited' on May 25, 1985.
The Company changed the name from Fairchem Speciality Limited to Privi Speciality Chemicals Limited on October 14, 2020.

FAQs for the comparison of Emmessar Biotech & Nutrition Ltd and Privi Speciality Chemicals Ltd

Which company has a larger market capitalization, Emmessar Biotech & Nutrition Ltd or Privi Speciality Chemicals Ltd?

Market cap of Emmessar Biotech & Nutrition Ltd is 12 Cr while Market cap of Privi Speciality Chemicals Ltd is 11,468 Cr

What are the key factors driving the stock performance of Emmessar Biotech & Nutrition Ltd and Privi Speciality Chemicals Ltd?

The stock performance of Emmessar Biotech & Nutrition Ltd and Privi Speciality Chemicals Ltd is primarily driven by its robust global client base, consistent revenue growth, strong operational efficiency, strategic investments in digital transformation, client acquisition, and the overall health of the industry. Both companies' performances are also influenced by macroeconomic conditions, currency fluctuations, and industry-specific trends.

What are the recent stock price for Emmessar Biotech & Nutrition Ltd and Privi Speciality Chemicals Ltd?

As of March 22, 2026, the Emmessar Biotech & Nutrition Ltd stock price is INR ₹24.34. On the other hand, Privi Speciality Chemicals Ltd stock price is INR ₹2935.9.

How do dividend payouts of Emmessar Biotech & Nutrition Ltd and Privi Speciality Chemicals Ltd compare?

To compare the dividend payouts of Emmessar Biotech & Nutrition Ltd and Privi Speciality Chemicals Ltd, examine their dividend payout ratio, which indicates how much the companies pay out relative to their share price and earnings. Moreover, consider the consistency and growth of their dividends to gauge their commitment towards returning value to the respective shareholders.

Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.